Regeneron reports strong Q3 2026 financial results
Total revenues reached $5.1B, up 36%, driven by record net sales. The pipeline continues progress in multiple indications including obesity and cancer.
Latest Regeneron News & Updates
See the latest news and media coverage for Regeneron. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biopharmaceutical company
regeneron.com- Headquarters
- Tarrytown, United States
- Company type
- Public company
- Number of employees
- 17,000+
- Industry
- Pharmaceuticals
Last updated
Latest news about Regeneron
In short: Regeneron expanded its Sanofi immunology alliance, reported strong Q2 earnings, and secured FDA approval for Pasatru.
Company announcements
Regeneron CHMP recommends alternative dosing for immunotherapy
The European Medicines Agency's Committee recommended approval of an alternative dosing regimen for the company's immunotherapy across skin, lung, and cervical cancer indications.
Regeneron expands Sanofi alliance to develop next-generation inflammation medicines
The agreement adds four long-acting antibody candidates, shares costs and profits equally, and provides up to $8 billion in potential payments to Regeneron.
Regeneron hosts Q3 2026 earnings call
Scheduled for Oct 30, 2026, the webcast is available at 8:30 AM EDT with registration options.
Media coverage
Regeneron Pharmaceuticals (REGN) Surges 11.55% Despite S&P 500 D
On October 30, 2026, Regeneron Pharmaceuticals Inc (REGN) saw its shares jump 11.55%, standing out...
Regeneron Pharma 3Q Sales Climb on Dupixent Growth
Regeneron Pharmaceuticals' quarterly revenue grew on record sales for a trio of drugs. The drugmaker said Friday third-quarter revenue climbed 36% to $5.12 billion. Analysts...
Regeneron, Sanofi Surge As Dupixent Wallops Sales Forecasts
Regeneron stock popped Thursday after its Sanofi-partnered allergic conditions drug, Dupixent, easily beat sales calls.
Regeneron, Sanofi Expand Alliance with $1 Billion Upfront, 4 Antibodies - France
Regeneron Pharmaceuticals and Sanofi announced Oct. 1, 2026, an expansion of their long-standing antibody collaboration, adding 4 next-generation, long-acting...
Never miss news about Regeneron
Track Regeneron and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Regeneron competitors & trending companies
Browse news for competitors to Regeneron and other trending companies.